🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: TR-701 FA 200 mg

Found 16 matching trials

A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study

PHASE2

Characterization of the safety profile of TR-701 Free Acid (FA) in patients...

Status

Completed

Location

Trius Investigator Site #118

Start Date

2012-02-15

Trial ID

NCT01519778

Treatments Being Tested

TR701 FA

Pharmacokinetics, Safety, and Tolerability of TR-701 Free Acid (FA) in Elderly Subjects

PHASE1

To compare the pharmacokinetic (PK) profile of TR-700 in elderly subjects v...

Status

Completed

Location

Trius Investigator Site 001

Start Date

2012-01-17

Trial ID

NCT01496677

Treatments Being Tested

TR-701 FA 200 mg TR-701 FA 200 mg

Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA)

PHASE1

The purpose of this study is to evaluate the safety, tolerability, and phar...

Status

Completed

Location

Covance Clinical Research Unit

Start Date

2009-09

Trial ID

NCT00983255

Treatments Being Tested

TR-701 FA for injection, 200 mg/vial TR-701 FA tablets

A Study of Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Participants From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (MK-1986-018)

PHASE3

This study will evaluate the safety, tolerability, and efficacy of tedizoli...

Status

Completed

Location

Rady Children's Hospital-San Diego ( Site 0118)

Start Date

2019-01-20

Trial ID

NCT03176134

Treatments Being Tested

Tedizolid phosphate Comparator

A Phase 1 TR-701 FA Study of Blood Pressure Response Post Tyramine Challenge

PHASE1

Phase 1 study to determine the effect of oral TR-701 FA on SBP response whe...

Status

Completed

Location

Trius Investigator Site 001

Start Date

2012-02

Trial ID

NCT01539473

Treatments Being Tested

TR-701 FA with Tyramine Placebo-controlled withTyramine

A PK and Safety Study in Subjects With Hepatic Impairment

PHASE1

Assess the single dose PK and safety of TR701 FA in subjects with Moderate ...

Status

Completed

Location

Trius Investigator Site 001

Start Date

2011-08

Trial ID

NCT01431833

Treatments Being Tested

TR-701 FA

A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013)

PHASE1

This is a study to assess the pharmacokinetics (PK) of tedizolid phosphate ...

Status

Completed

Location

Multiple Locations

Start Date

2016-05-02

Trial ID

NCT02750761

Treatments Being Tested

Tedizolid Phosphate (IV)Tedizolid Phosphate (oral suspension)

Pharmacokinetic (PK) Study of Oral and IV TR-701 FA in Adolescent Patients

PHASE1

This is an open-label, multi-center, two-part, parallel-design study to ass...

Status

Completed

Location

Multiple Locations

Start Date

2010-06-02

Trial ID

NCT01156077

Treatments Being Tested

TR-701 FA TR-701 FA

Tedizolid Phosphate (TR-701 FA, MK-1986) vs Linezolid for the Treatment of Nosocomial Pneumonia (MK-1986-002)

PHASE3

This is a 1:1 ratio, randomized, double-blind, double-dummy, multicenter, g...

Status

Completed

Location

Multiple Locations

Start Date

2014-01-06

Trial ID

NCT02019420

Treatments Being Tested

Tedizolid phosphate Linezolid

TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections

PHASE3

This is a randomized, double-blind, double-dummy, multicenter, global Phase...

Status

Completed

Location

Trius investigator site 159

Start Date

2011-09-15

Trial ID

NCT01421511

Treatments Being Tested

TR-701 FA Linezolid

Previous Next